Text this: Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

             ___     _    _    __   __    _  __  
  ____      / _ \\  | \  / ||  \ \\/ //  | |/ // 
 |    \\   / //\ \\ |  \/  ||   \ ` //   | ' //  
 | [] ||  |  ___  ||| .  . ||    | ||    | . \\  
 |  __//  |_||  |_|||_|\/|_||    |_||    |_|\_\\ 
 |_|`-`   `-`   `-` `-`  `-`     `-`'    `-` --` 
 `-`